Confluence Wealth Services’s Halozyme HALO Stock Holding History

Confluence Wealth Services’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-74	Closed	-$2K	–	617
2021 Q4	$2K	Buy	+74	New	+$2.76K	﹤0.01%	1148

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Confluence Wealth Services's HALO Position: Q1 2022 in Review

Confluence Wealth Services sold out of Halozyme (HALO) in Q1 2022, closing a stake of 74 shares — an estimated $2K sold.

Confluence Wealth Services first reported a position in HALO in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 316 funds tracked by Wall St. Rank hold HALO as of Q1 2022.

Confluence Wealth Services reported no remaining Halozyme position as of Q1 2022 after selling out during the quarter.
Confluence Wealth Services sold 74 Halozyme shares in Q1 2022, an estimated $2K.
Confluence Wealth Services first reported a position in Halozyme in Q4 2021 and held it in 1 quarter.
Confluence Wealth Services's Halozyme position peaked at $2K in Q4 2021.
316 funds tracked by Wall St. Rank held Halozyme as of Q1 2022.

Based on Confluence Wealth Services's 13F filing for Q1 2022, filed 26 Apr 2022.